Search

everythinglearnresearchcommunity

for

Search:↓

Certain bacteria from the Citrullus colocynthis plant may be a new source of antibiotics to fight drug-resistant diseases.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

ADT-G may be a useful indicator of increased androgen levels in women with acne and can be lowered with certain birth control pills.

IP-PA1 helps grow hair in mice and affects human cell growth-related genes differently than traditional hair growth treatments.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

Hydroxyl radicals cause hair follicle cell death during chemotherapy by reducing Bcl-2 protein levels.

Certain cancer drugs interact with skin bacteria to cause acne-like rashes.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

A 25-year-old man with multiple skin tumors was successfully treated with acitretin and methotrexate.

Histone H4, released by cells exposed to colchicine, can cause hair loss by inhibiting cell growth and enzyme activity.

Using DNase enzymes to break down harmful NETs could be a new treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis.

A blood pressure drug, diltiazem, may also help treat influenza.

Using A132 hair dye with sunlight can cause skin damage and hair loss.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Combining terbinafine and mitotane effectively treated a schnauzer's skin infection and hormone disorder.

Early diagnosis and treatment of EGFR inhibitor-induced folliculitis decalvans can prevent permanent hair loss.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

The oncoprotein causes abnormal hair growth without increasing skin cancer risk.

Septin4 helps kill colon cancer cells by working with the protein BAX.

Botulinum toxin A helped a patient recover from dissecting folliculitis when antibiotics failed.

Topical vasoconstrictors do not reduce chemotherapy effectiveness against leukemia in mice.

Loss of Dnmt3a and Dnmt3b increases aggressive skin tumors by affecting PPAR-γ.

DNCB helps regrow hair in alopecia areata patients, but safer alternatives are needed.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Nanotechnology can effectively deliver antimicrobial peptides for treating infections.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.